ESPAC-4 long-term follow-up: shall we choose gemcitabine and capecitabine as adjuvant therapy for elderly and low-risk pancreatic adenocarcinoma following surgical resection?
@article{APC8830,
author = {Aaron Bertolo and Pamela Hodul and Dae Won Kim},
title = {ESPAC-4 long-term follow-up: shall we choose gemcitabine and capecitabine as adjuvant therapy for elderly and low-risk pancreatic adenocarcinoma following surgical resection?},
journal = {Annals of Pancreatic Cancer},
volume = {9},
number = {0},
year = {2026},
keywords = {},
abstract = {},
issn = {2616-2741}, url = {https://apc.amegroups.org/article/view/8830}
}